刊物主题:Oncology; Pharmacology/Toxicology; Cancer Research;
出版者:Springer Berlin Heidelberg
ISSN:1432-0843
卷排序:79
文摘
BackgroundThe aim of our study was to determine the maximum tolerated dose (MTD) and recommended dose (RD) of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) plus carboplatin in combination with thoracic radiotherapy for patients with locally advanced stage III non-small cell lung cancer (NSCLC).